GlassScriptPhysician profile
Avraham Henoch
NPI 1235113044
$14,591.59
in general payments reported to CMS, 2019-2025
57 companies · $1,250 in 2025
The $1,250 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,427 · 2020: $2,738 · 2021: $3,191 · 2022: $2,261 · 2023: $1,592 · 2024: $1,135 · 2025: $1,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,975.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,355.03 | 2019-2025 | |
| Allergan, INC. | $1,290.50 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,263.88 | 2019-2025 | Xifaxan, Relistor, Trulance |
| Glaxosmithkline, LLC. | $1,108.76 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $842.98 | 2019-2025 | Farxiga, Fasenra, Tezspire |
| Amgen INC. | $778.90 | 2019-2025 | Otezla, Repatha, Otezla |
| Amarin Pharma, INC. | $573.04 | 2019-2021 | |
| Pfizer INC. | $453.01 | 2019-2025 | |
| Nestle Healthcare Nutrition INC. | $403.45 | 2020-2023 | |
| Novo Nordisk INC | $401.36 | 2019-2025 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $392.02 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $382.28 | 2019-2025 | |
| Lilly USA, LLC | $377.27 | 2019-2025 | Mounjaro, Zepbound |
| Mannkind Corporation | $354.45 | 2019-2023 | Afrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $291.86 | 2019-2023 | Jardiance |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avraham Henoch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.